Trial Profile
Patient-reported adherence to capecitabine on XELOX as adjuvant therapy for colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 12 Aug 2015 New trial record